Skip to main content
Top
Published in: Journal of Translational Medicine 1/2014

Open Access 01-12-2014 | Meeting report

Routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain

Authors: M Ángela Aznar, Ignacio Melero, José I Quetglas

Published in: Journal of Translational Medicine | Issue 1/2014

Login to get access

Abstract

New approaches to generate effective anticancer responses by either inducing immune responses or inhibiting immunosuppression are under development to improve efficacy in patients. On March 4-5th, 2014, a symposium was held in Pamplona, Spain, to report the new strategies showing preclinical and clinical results regarding translational research efforts on the topic. Participants interacted through oral presentations of 15 speakers and further discussions on topics that included novel therapeutic agents for cancer immunotherapy, viral vectors and interferon-based approaches, experimental tumor imaging and immunostimulatory monoclonal antibodies. Promising agents to target cancer cells and therapeutic approaches that are under translation from bench to patients were presented.
Literature
1.
go back to reference Kroemer G, Galluzzi L, Kepp O, Zitvogel L: Immunogenic cell death in cancer therapy. Annu Rev Immunol. 2013, 31: 51-72. 10.1146/annurev-immunol-032712-100008.CrossRefPubMed Kroemer G, Galluzzi L, Kepp O, Zitvogel L: Immunogenic cell death in cancer therapy. Annu Rev Immunol. 2013, 31: 51-72. 10.1146/annurev-immunol-032712-100008.CrossRefPubMed
2.
go back to reference Quetglas JI, Dubrot J, Bezunartea J, Sanmamed MF, Hervas-Stubbs S, Smerdou C, Melero I: Immunotherapeutic synergy between anti-CD137 mAb and intratumoral administration of a cytopathic Semliki Forest virus encoding IL-12. Mol Ther. 2012, 20 (9): 1664-1675. 10.1038/mt.2012.56.PubMedCentralCrossRefPubMed Quetglas JI, Dubrot J, Bezunartea J, Sanmamed MF, Hervas-Stubbs S, Smerdou C, Melero I: Immunotherapeutic synergy between anti-CD137 mAb and intratumoral administration of a cytopathic Semliki Forest virus encoding IL-12. Mol Ther. 2012, 20 (9): 1664-1675. 10.1038/mt.2012.56.PubMedCentralCrossRefPubMed
3.
go back to reference Hervas-Stubbs S, Riezu-Boj JI, Gonzalez I, Mancheño U, Dubrot J, Azpilicueta A, Gabari I, Palazon A, Aranguren A, Ruiz J, Prieto J, Larrea E, Melero I: Effects of IFN-alpha as a signal-3 cytokine on human naive and antigen-experienced CD8(+) T cells. Eur J Immunol. 2010, 40 (12): 3389-3402. 10.1002/eji.201040664.CrossRefPubMed Hervas-Stubbs S, Riezu-Boj JI, Gonzalez I, Mancheño U, Dubrot J, Azpilicueta A, Gabari I, Palazon A, Aranguren A, Ruiz J, Prieto J, Larrea E, Melero I: Effects of IFN-alpha as a signal-3 cytokine on human naive and antigen-experienced CD8(+) T cells. Eur J Immunol. 2010, 40 (12): 3389-3402. 10.1002/eji.201040664.CrossRefPubMed
4.
go back to reference Hervas-Stubbs S, Riezu-Boj JI, Mancheño U, Rueda P, Lopez L, Alignani D, Rodríguez-García E, Thieblemont N, Leclerc C: Conventional but Not Plasmacytoid Dendritic Cells Foster the Systemic Virus-Induced Type I IFN Response Needed for Efficient CD8 T Cell Priming. J Immunol. 2014, [Epub ahead of print] Hervas-Stubbs S, Riezu-Boj JI, Mancheño U, Rueda P, Lopez L, Alignani D, Rodríguez-García E, Thieblemont N, Leclerc C: Conventional but Not Plasmacytoid Dendritic Cells Foster the Systemic Virus-Induced Type I IFN Response Needed for Efficient CD8 T Cell Priming. J Immunol. 2014, [Epub ahead of print]
5.
go back to reference Iborra S, Izquierdo HM, Martínez-López M, Blanco-Menéndez N, Reis e Sousa C, Sancho D: The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice. J Clin Invest. 2012, 122 (5): 1628-1643. 10.1172/JCI60660.PubMedCentralCrossRefPubMed Iborra S, Izquierdo HM, Martínez-López M, Blanco-Menéndez N, Reis e Sousa C, Sancho D: The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice. J Clin Invest. 2012, 122 (5): 1628-1643. 10.1172/JCI60660.PubMedCentralCrossRefPubMed
6.
go back to reference Deguine J, Breart B, Lemaître F, Bousso P: Cutting edge: tumor-targeting antibodies enhance NKG2D-mediated NK cell cytotoxicity by stabilizing NK cell-tumor cell interactions. J Immunol. 2012, 189 (12): 5493-5497. 10.4049/jimmunol.1202065.CrossRefPubMed Deguine J, Breart B, Lemaître F, Bousso P: Cutting edge: tumor-targeting antibodies enhance NKG2D-mediated NK cell cytotoxicity by stabilizing NK cell-tumor cell interactions. J Immunol. 2012, 189 (12): 5493-5497. 10.4049/jimmunol.1202065.CrossRefPubMed
7.
go back to reference Montalvao F, Garcia Z, Celli S, Breart B, Deguine J, Van Rooijen N, Bousso P: The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging. J Clin Invest. 2013, 123 (12): 5098-5103. 10.1172/JCI70972.PubMedCentralCrossRefPubMed Montalvao F, Garcia Z, Celli S, Breart B, Deguine J, Van Rooijen N, Bousso P: The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging. J Clin Invest. 2013, 123 (12): 5098-5103. 10.1172/JCI70972.PubMedCentralCrossRefPubMed
8.
go back to reference Morales-Kastresana A, Sanmamed MF, Rodriguez I, Palazon A, Martinez-Forero I, Labiano S, Hervas-Stubbs S, Sangro B, Ochoa C, Rouzaut A, Azpilikueta A, Bolaños E, Jure-Kunkel M, Gütgemann I, Melero I: Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model. Clin Cancer Res. 2013, 19 (22): 6151-6162. 10.1158/1078-0432.CCR-13-1189.CrossRefPubMed Morales-Kastresana A, Sanmamed MF, Rodriguez I, Palazon A, Martinez-Forero I, Labiano S, Hervas-Stubbs S, Sangro B, Ochoa C, Rouzaut A, Azpilikueta A, Bolaños E, Jure-Kunkel M, Gütgemann I, Melero I: Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model. Clin Cancer Res. 2013, 19 (22): 6151-6162. 10.1158/1078-0432.CCR-13-1189.CrossRefPubMed
9.
go back to reference Ochoa MC, Fioravanti J, Rodriguez I, Hervas-Stubbs S, Azpilikueta A, Mazzolini G, Gúrpide A, Prieto J, Pardo J, Berraondo P, Melero I: Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein. Cancer Res. 2013, 73 (1): 139-149. 10.1158/0008-5472.CAN-12-2660.CrossRefPubMed Ochoa MC, Fioravanti J, Rodriguez I, Hervas-Stubbs S, Azpilikueta A, Mazzolini G, Gúrpide A, Prieto J, Pardo J, Berraondo P, Melero I: Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein. Cancer Res. 2013, 73 (1): 139-149. 10.1158/0008-5472.CAN-12-2660.CrossRefPubMed
10.
go back to reference Ascierto PA, Kalos M, Schaer DA, Callahan MK, Wolchok JD: Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types. Clin Cancer Res. 2013, 19 (5): 1009-1020. 10.1158/1078-0432.CCR-12-2982.CrossRefPubMed Ascierto PA, Kalos M, Schaer DA, Callahan MK, Wolchok JD: Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types. Clin Cancer Res. 2013, 19 (5): 1009-1020. 10.1158/1078-0432.CCR-12-2982.CrossRefPubMed
11.
go back to reference Kohrt HE, Houot R, Goldstein MJ, Weiskopf K, Alizadeh AA, Brody J, Müller A, Pachynski R, Czerwinski D, Coutre S, Chao MP, Chen L, Tedder TF, Levy R: CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies. Blood. 2011, 117 (8): 2423-2432. 10.1182/blood-2010-08-301945.PubMedCentralCrossRefPubMed Kohrt HE, Houot R, Goldstein MJ, Weiskopf K, Alizadeh AA, Brody J, Müller A, Pachynski R, Czerwinski D, Coutre S, Chao MP, Chen L, Tedder TF, Levy R: CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies. Blood. 2011, 117 (8): 2423-2432. 10.1182/blood-2010-08-301945.PubMedCentralCrossRefPubMed
12.
go back to reference Kohrt HE, Colevas AD, Houot R, Weiskopf K, Goldstein MJ, Lund P, Mueller A, Sagiv-Barfi I, Marabelle A, Lira R, Troutner E, Richards L, Rajapaska A, Hebb J, Chester C, Waller E, Ostashko A, Weng WK, Chen L, Czerwinski D, Fu YX, Sunwoo J, Levy R: Targeting CD137 enhances the efficacy of cetuximab. J Clin Invest. 2014, 124 (6): 2668-2682. 10.1172/JCI73014.PubMedCentralCrossRefPubMed Kohrt HE, Colevas AD, Houot R, Weiskopf K, Goldstein MJ, Lund P, Mueller A, Sagiv-Barfi I, Marabelle A, Lira R, Troutner E, Richards L, Rajapaska A, Hebb J, Chester C, Waller E, Ostashko A, Weng WK, Chen L, Czerwinski D, Fu YX, Sunwoo J, Levy R: Targeting CD137 enhances the efficacy of cetuximab. J Clin Invest. 2014, 124 (6): 2668-2682. 10.1172/JCI73014.PubMedCentralCrossRefPubMed
13.
go back to reference Casares N, Rudilla F, Arribillaga L, Llopiz D, Riezu-Boj JI, Lozano T, López-Sagaseta J, Guembe L, Sarobe P, Prieto J, Borrás-Cuesta F, Lasarte JJ: A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice. J Immunol. 2010, 185 (9): 5150-5159. 10.4049/jimmunol.1001114.CrossRefPubMed Casares N, Rudilla F, Arribillaga L, Llopiz D, Riezu-Boj JI, Lozano T, López-Sagaseta J, Guembe L, Sarobe P, Prieto J, Borrás-Cuesta F, Lasarte JJ: A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice. J Immunol. 2010, 185 (9): 5150-5159. 10.4049/jimmunol.1001114.CrossRefPubMed
14.
go back to reference Tormo D, Checińska A, Alonso-Curbelo D, Pérez-Guijarro E, Cañón E, Riveiro-Falkenbach E, Calvo TG, Larribere L, Megías D, Mulero F, Piris MA, Dash R, Barral PM, Rodríguez-Peralto JL, Ortiz-Romero P, Tüting T, Fisher PB, Soengas MS: Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. Cancer Cell. 2009, 16 (2): 103-114. 10.1016/j.ccr.2009.07.004.PubMedCentralCrossRefPubMed Tormo D, Checińska A, Alonso-Curbelo D, Pérez-Guijarro E, Cañón E, Riveiro-Falkenbach E, Calvo TG, Larribere L, Megías D, Mulero F, Piris MA, Dash R, Barral PM, Rodríguez-Peralto JL, Ortiz-Romero P, Tüting T, Fisher PB, Soengas MS: Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. Cancer Cell. 2009, 16 (2): 103-114. 10.1016/j.ccr.2009.07.004.PubMedCentralCrossRefPubMed
15.
go back to reference Alonso-Curbelo D, Soengas MS: Self-killing of melanoma cells by cytosolic delivery of dsRNA: wiring innate immunity for a coordinated mobilization of endosomes, autophagosomes and the apoptotic machinery in tumor cells. Autophagy. 2010, 6 (1): 148-150. 10.4161/auto.6.1.10464.CrossRefPubMed Alonso-Curbelo D, Soengas MS: Self-killing of melanoma cells by cytosolic delivery of dsRNA: wiring innate immunity for a coordinated mobilization of endosomes, autophagosomes and the apoptotic machinery in tumor cells. Autophagy. 2010, 6 (1): 148-150. 10.4161/auto.6.1.10464.CrossRefPubMed
16.
go back to reference Gilboa E, McNamara J, Pastor F: Use of oligonucleotide aptamer ligands to modulate the function of immune receptors. Clin Cancer Res. 2013, 19 (5): 1054-1062. 10.1158/1078-0432.CCR-12-2067.CrossRefPubMed Gilboa E, McNamara J, Pastor F: Use of oligonucleotide aptamer ligands to modulate the function of immune receptors. Clin Cancer Res. 2013, 19 (5): 1054-1062. 10.1158/1078-0432.CCR-12-2067.CrossRefPubMed
17.
go back to reference Cuesta AM, Sánchez-Martín D, Sanz L, Bonet J, Compte M, Kremer L, Blanco FJ, Oliva B, Alvarez-Vallina L: In vivo tumor targeting and imaging with engineered trivalent antibody fragments containing collagen-derived sequences. PLoS One. 2009, 4 (4): e5381-10.1371/journal.pone.0005381.PubMedCentralCrossRefPubMed Cuesta AM, Sánchez-Martín D, Sanz L, Bonet J, Compte M, Kremer L, Blanco FJ, Oliva B, Alvarez-Vallina L: In vivo tumor targeting and imaging with engineered trivalent antibody fragments containing collagen-derived sequences. PLoS One. 2009, 4 (4): e5381-10.1371/journal.pone.0005381.PubMedCentralCrossRefPubMed
18.
go back to reference Blanco-Toribio A, Sainz-Pastor N, Alvarez-Cienfuegos A, Merino N, Cuesta AM, Sánchez-Martín D, Bonet J, Santos-Valle P, Sanz L, Oliva B, Blanco FJ, Alvarez-Vallina L: Generation and characterization of monospecific and bispecific hexavalent trimerbodies. MAbs. 2013, 5 (1): 70-79. 10.4161/mabs.22698.PubMedCentralCrossRefPubMed Blanco-Toribio A, Sainz-Pastor N, Alvarez-Cienfuegos A, Merino N, Cuesta AM, Sánchez-Martín D, Bonet J, Santos-Valle P, Sanz L, Oliva B, Blanco FJ, Alvarez-Vallina L: Generation and characterization of monospecific and bispecific hexavalent trimerbodies. MAbs. 2013, 5 (1): 70-79. 10.4161/mabs.22698.PubMedCentralCrossRefPubMed
Metadata
Title
Routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain
Authors
M Ángela Aznar
Ignacio Melero
José I Quetglas
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2014
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-12-202

Other articles of this Issue 1/2014

Journal of Translational Medicine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.